Syra Health Corp.
SYRA
$0.3401
-$0.0189-5.27%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -66.30% | -63.83% | -51.22% | -38.73% | -- |
Total Depreciation and Amortization | 20.48% | -45.41% | -62.57% | 832.89% | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -103.14% | 381.67% | -3.80% | -109.42% | -- |
Change in Net Operating Assets | -363.36% | -406.72% | -144.41% | 112.80% | -- |
Cash from Operations | -101.23% | -96.87% | -67.61% | -22.95% | -- |
Capital Expenditure | 81.56% | 91.06% | 91.45% | 87.39% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 81.56% | 91.06% | 91.45% | 87.39% | -- |
Total Debt Issued | -100.00% | -68.11% | -64.41% | 4.69% | -- |
Total Debt Repaid | 43.69% | 29.80% | 42.96% | 1.68% | -- |
Issuance of Common Stock | -- | 1,100.70% | 367.48% | 129.59% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 179.77% | 151.98% | 125.06% | 100.00% | -- |
Cash from Financing | 338.76% | 332.51% | 210.75% | 166.72% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 511.91% | 257.79% | 1,185.74% | 3,488.62% | -- |